enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. US FDA approves Ionis Pharma's genetic disorder drug - AOL

   www.aol.com/news/us-fda-approves-ionis-pharmas...

   By Mariam Sunny and Kamal Choudhury (Reuters) -The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it the company's first wholly ...

3. Finance News & Latest Business Headlines - AOL.com

   homepage.aol.com/finance

   Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here. Finance News & Latest Business Headlines - AOL.com

4. News, Politics, Sports, Mail & Latest Headlines - AOL.com

   homepage.aol.com/news

   Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL

5. News, Politics, Sports, Mail & Latest Headlines - AOL.com

   firefox-startpage.aol.com

   Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.

6. Stock market news live updates: Stocks soar to kick off key ...

   www.aol.com/finance/stock-market-news-live...

   U.S. stocks rose on Monday to begin a key week in which Wall Street awaits earnings from some of the market’s biggest players.. The S&P 500 climbed about 1.2% while the Dow Jones Industrial ...

7. Stock market news live updates: Stocks fall, yields rise as ...

   www.aol.com/finance/stock-market-news-live...

   U.S. stocks snapped a winning streak to end a back-and-forth session lower Wednesday as a rally that kicked off the week faltered despite better-than-feared earnings reports.. The S&P 500 sank 0.7 ...

8. Ionis Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Ionis_Pharmaceuticals

   Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...

9. Ionis (IONS) Q1 Loss Widens Year Over Year, Sales Miss - AOL

   www.aol.com/news/ionis-ions-q1-loss-widens...

   Ionis (IONS) Q1 adjusted loss per share was wider than the year-ago figure. The company maintains its guidance for 2021.